Phathom Pharmaceuticals Statistics

Total Valuation

PHAT has a market cap or net worth of $509.41 million. The enterprise value is $693.73 million.

Market Cap	509.41M
Enterprise Value	693.73M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

PHAT has 68.38 million shares outstanding. The number of shares has increased by 26.36% in one year.

Current Share Class	68.38M
Shares Outstanding	68.38M
Shares Change (YoY)	+26.36%
Shares Change (QoQ)	+10.37%
Owned by Insiders (%)	3.69%
Owned by Institutions (%)	79.96%
Float	55.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.94
Forward PS	3.55
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	26.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.73

Current Ratio	5.73
Quick Ratio	5.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.33

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-57.67%
Return on Capital (ROIC)	-66.59%
Revenue Per Employee	$58,119
Profits Per Employee	-$750,985
Employee Count	452
Asset Turnover	0.08
Inventory Turnover	2.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.76% in the last 52 weeks. The beta is 0.54, so PHAT's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-14.76%
50-Day Moving Average	12.24
200-Day Moving Average	12.13
Relative Strength Index (RSI)	29.68
Average Volume (20 Days)	1,030,176

Short Selling Information

The latest short interest is 14.05 million, so 20.55% of the outstanding shares have been sold short.

Short Interest	14.05M
Short Previous Month	14.66M
Short % of Shares Out	20.55%
Short % of Float	25.22%
Short Ratio (days to cover)	7.98

Income Statement

In the last 12 months, PHAT had revenue of $26.27 million and -$339.45 million in losses. Loss per share was -$5.68.

Revenue	26.27M
Gross Profit	21.95M
Operating Income	-287.93M
Pretax Income	-297.11M
Net Income	-339.45M
EBITDA	-287.14M
EBIT	-287.93M
Loss Per Share	-$5.68

Full Income Statement

Balance Sheet

The company has $334.68 million in cash and $518.99 million in debt, giving a net cash position of -$184.31 million or -$2.70 per share.

Cash & Cash Equivalents	334.68M
Total Debt	518.99M
Net Cash	-184.31M
Net Cash Per Share	-$2.70
Equity (Book Value)	-187.11M
Book Value Per Share	-2.74
Working Capital	308.53M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$247.11 million and capital expenditures -$605,000, giving a free cash flow of -$247.72 million.

Operating Cash Flow	-247.11M
Capital Expenditures	-605,000
Free Cash Flow	-247.72M
FCF Per Share	-$3.62

Full Cash Flow Statement

Margins

Gross Margin	83.54%
Operating Margin	-1,096.02%
Pretax Margin	-1,292.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHAT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.36%
Shareholder Yield	-26.36%
Earnings Yield	-66.63%
FCF Yield	-48.63%

Analyst Forecast

The average price target for PHAT is $23.00, which is 208.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.00
Price Target Difference	208.73%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	232.35%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PHAT has an Altman Z-Score of -5.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.08
Piotroski F-Score	1